Roche's new, single-dose flu drug gets the green light at a hard charging FDA, breaking into record-setting territory
Roche got the first new landmark drug approval we’ve seen in flu for 20 years — while setting a record on new drug approvals for the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
